TEST:

Canhelp-UriBLAD

"...the Kebang Gene R&D team jointly published a paper in 'European Urology Oncology' (IF=8.2) published the research results titled 'Large-scale Prospective Validation Study of a Multiplex RNA Urine Test for Noninvasive Detection of Upper Tract Urothelial Carcinoma' in the journal . This study conducted a prospective multi-center clinical trial and confirmed that the urothelial cancer gene detection method (Canhelp ® -UriBLAD Assay) based on gene expression profiles can effectively identify upper urinary tract urothelial cancer and other urinary system diseases. The overall sensitivity was 90.16% and the specificity was 88.89%." "

"Recently, the bladder cancer mRNA detection technology (UriBLAD ® mRNA Test) independently developed by Canbang Gene was authorized by the United States Patent and Trademark Office (USPTO) for an invention patent (patent number: US11401560B2). The invention discloses a group of genes and related kits for non-invasive detection of bladder cancer, provides a method for non-invasive detection of bladder cancer in urine samples, and can be used for early diagnosis and recurrence monitoring of bladder cancer."